Single-cell RNA sequencing and FACS analysis revealed that oHSV decreased tumor-associated macrophages and boosted tumor-infiltrating lymphocytes, including activated CD8+ T and Th1 cells, leading to enhanced PDAC responsiveness to immunotherapy [24]. Here, CD8A is linked to neoplasm.